Indegene Hosts Inaugural Strategic Advisory Board Meeting Chaired By Renowned Global Biopharma Leader Jill DeSimone
April 02, 2024 07:00 ET
|
Indegene Inc
Indegene Hosts Inaugural Strategic Advisory Board Meeting Chaired By Renowned Global Biopharma Leader Jill DeSimone
Empire State Development Announces 10 Startups Selected For Round Seven of Luminate NY
March 28, 2024 13:07 ET
|
Luminate
Empire State Development announces the companies selected to participate in cohort seven of Luminate NY's business accelerator and investment fund.
Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy
March 27, 2024 23:43 ET
|
Indegene Inc
Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy
ON Partners Report Reveals Executive Women Secure Higher Base Salaries Than Men
March 27, 2024 12:28 ET
|
ON Partners
CLEVELAND, March 27, 2024 (GLOBE NEWSWIRE) -- This month, ON Partners, a pure-play retained executive search firm building C-level and board leadership teams, released its 2024 Women’s Report in...
Intelligencia AI Ranks No. 90 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies
March 20, 2024 09:18 ET
|
Intelligencia AI
Inc. magazine recently revealed that Intelligencia AI, a provider of AI-powered decision-making solutions for the pharmaceutical industry, ranks No. 90.
MasterControl Generative AI-Powered Exam Builder Beta Program Kicks Off
February 27, 2024 10:00 ET
|
MasterControl
Effective training programs are vital to quality teams. With MasterControl’s AI-powered Auto Exam Builder, quality professionals save significant time.
BioNTX Champions Talent Retention in the Texas Life Sciences Industry
February 15, 2024 10:00 ET
|
Bio North Texas
DALLAS, Feb. 15, 2024 (GLOBE NEWSWIRE) -- BioNTX, the leading biotechnology and healthcare innovation trade organization in North Texas, continues its commitment to nurturing the thriving, regional,...
Kneat Announces Closing of $20 Million Bought Deal Including Full Exercise of Over-Allotment Option
February 14, 2024 09:04 ET
|
kneat.com, inc.
Kneat announced the closing of its bought deal: it issued 6,153,880 common shares at $3.25 per share for gross proceeds of $20,000,110.
Kneat to Announce 2023 Fourth-Quarter and Fiscal Year Financial Results February 21, 2024
February 13, 2024 17:12 ET
|
kneat.com, inc.
Kneat will announce its Q4 2023 results on February 21, 2024 after market close and host a call for investors the following morning.
Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors
February 07, 2024 07:00 ET
|
Avextra AG
Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors